Nevan C Elam has bought stock on 2 days since Mar 2025

Nevan Charles Elam is the founder and Chief Executive Officer of Rezolute, Inc., a biopharmaceutical company focused on orphan and metabolic diseases, which he established in January 2010( He has served as CEO since January 31, 2013, and has held the position of Acting Chairman of the Board since May 2022( Elam holds a J.D. from Harvard Law School and a B.A. from Howard University, and brings over 30 years of healthcare and technology leadership experience(

Prior to founding Rezolute, Elam held senior leadership positions across the life sciences and technology sectors, including Senior Vice President at Nektar Therapeutics, where he led the Pulmonary Business Unit and spun out Pearl Therapeutics (subsequently acquired by AstraZeneca for $1 billion) and Aerogen( He was also co-founder and Chief Financial Officer of e2open, a web-based supply chain platform company( Early in his career, Elam served as a corporate partner at Wilson Sonsini Goodrich & Rosati law firm, advising major pharmaceutical and technology companies and negotiating significant transactions, including the sale of NeXT to Apple( His diverse expertise in legal, operating, and finance leadership has positioned Rezolute as a leader in treating congenital hyperinsulinism and advancing novel therapeutics for metabolic and rare diseases(

Written by Perplexity from public sources.